Clinical outcome of an early psychosis intervention program: evaluation in a real-world context

References

• Falloon I R.H, Kydd R R, Coverdale J H, Laldlaw T M. Early detection and intervention for initial episodes of schizophrenia. Schizophrenia Bulletin 1996; 22: 271–282
   PubMed Web of Science ®Google Scholar
• McGlashan T H. Early detection and intervention in schizophrenia: research. Schizophrenia Bulletin 1996; 22: 327–345
   PubMed Web of Science ®Google Scholar
• Yung A, McGorry P. The prodromal phase of first-episode psychosis: past and current conceptualisations. Schizophrenia Bulletin 1996; 22: 353–370
   PubMed Web of Science ®Google Scholar
• McGorry P, Yung A, Phillips L, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 2002; 59: 921–928
   PubMed Web of Science ®Google Scholar
• Yung A, Phillips L, McGorry P, et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. [Comment]. British Journal of Psychiatry 1998; 172: 14–20
   Web of Science ®Google Scholar
• McGorry P, Yung A, Phillips L. Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophrenia Research 2001; 5: 17–29
   Google Scholar
• Wyatt R, Green M, Tuma A. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data. Psychological Medicine 1997; 45: 174–176
   Google Scholar
• Beiser M E.D, Fleming J, Iaconc W. Establishing the onset of psychotic illness. American Journal of Psychiatry 1993; 150: 1349–1354
   PubMed Web of Science ®Google Scholar
• Larsen T, McGlashan T, Moe L. First-episode schizophrenia. I. Early course parameters. Schizophrenia Bulletin 1996; 22: 241–256
   PubMed Web of Science ®Google Scholar
• Johnstone E, Crow T, Johnson A, MacMillan J. The Northwick Park study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission. British Journal of Psychiatry 1996; 148: 115–120
   Google Scholar
• Loebal A, Lieberman J, Jose M, et al. Duration of psychosis and outcome in first episode schizophrenia. American Journal of Psychiatry 1992; 149: 1183–1188
   PubMedGoogle Scholar
• McGorry P, Edwards J, Mihalopoulos C, Harrigan S, Jackson H, EPPIC. An evolving system of early detection and optimal management. Schizophrenia Bulletin 1996; 22: 305–326
   PubMed Web of Science ®Google Scholar
• Ho B-C, Andreason N, Flaum M, Nopoulos P, Miller D. Untreated initial psychosis: its relation to quality of life and symptom remission in first episode schizophrenia. American Journal of Psychiatry 2000; 157: 808–815
   PubMed Web of Science ®Google Scholar
• Craig T, Bromet E, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a firstadmission series?. American Journal of Psychiatry 2000; 157: 60–66
   PubMedGoogle Scholar
• McGorry P. Evaluating the importance of reducing the duration of untreated psychosis. Australian and New Zealand Journal of Psychiatry 2000:; 34: S145–S149
   PubMed Web of Science ®Google Scholar
• Johannessen J, McGlashan T, Larsen T, et al. Early detection strategies for untreated first-episode psychosis. Schizophrenia Research 2001; 51: 39–46
   PubMed Web of Science ®Google Scholar
• Norman R, Malla A. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychological Medicine 2001; 31: 381–400
   PubMed Web of Science ®Google Scholar
• Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophrenia Research 2001; 49: 231–241
   PubMedGoogle Scholar
• Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala L. Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophrenia Research 2001; 47: 215–222
   PubMedGoogle Scholar
• Malla A, Norman R, Manchanda R, et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophrenia Research 2002; 54: 231–242
   PubMed Web of Science ®Google Scholar
• Kalla O, Aaltonen J, Wahl-strom J, et al. Duration of untreated psychosis and its correlated in first-episode psychosis in Finland and Spain. Acta Psychiatrica Scandinavica 2002; 106: 265–275
   PubMed Web of Science ®Google Scholar
• May P, Dixon W, Yale C, Thiele D, Kraude W. Schizophrenia. A follow-up study of the results of five forms of treatment. Archives of General Psychiatry 1981; 38: 776–784
   PubMedGoogle Scholar
• Birchwood M, McGorry P, Jackson H. Early intervention in schizophrenia. British Journal of Psychiatry 1997; 170: 2–5
   PubMed Web of Science ®Google Scholar
• Linszen D, Dingemans P, Lenior M. Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications. Schizophrenia Research 2001; 51: 55–61
   PubMed Web of Science ®Google Scholar
• McGorry P. Early psychosis reform: too fast or too slow?. Acta Psychiatrica Scandinavica 2002; 106: 249–251
   PubMedGoogle Scholar
• Birchwood M, Todd P, Jackson C. Early intervention in psychosis: The critical-period hypothesis. International Clinical Psychopharmacology 1998:; 13:S31–S40
   Google Scholar
• McEvoy J, Hogarty G, Steingard S. Optimal dose of neuroleptic in acute schizophrenia. Archives of General Psychiatry 1991; 48: 739–745
   PubMed Web of Science ®Google Scholar
• Kopala L. Symptoms in neuroleptic naive first episodes schizophrenia: response to risperidone. Biological Psychiatry 1996; 39: 296–298
   PubMed Web of Science ®Google Scholar
• Farde E, Nordstrom A, Wissal F, et al. Positron emmision tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Archives of General Psychiatry 1992; 49: 533–544
   Google Scholar
• Kapur S, Remington G, Jones C, et al. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. American Journal of Psychiatry 1996; 153: 948–950
   PubMed Web of Science ®Google Scholar
• Lehtinen V, Aaltonen J, Koffert T, Rakkolainen V, Syvalahti E. Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neurolpitisation always needed?. European Psychiatry 2000; 15: 312–320
   PubMed Web of Science ®Google Scholar
• Cullberg J, Levander S, Holmqvist R, Mattsson M, Wieselgren I-M One-year outcome in first episode psychosis patients in the Swedish Parachute project. Acta Psychiatrica Scandinavica 2002; 106: 276–285
   PubMed Web of Science ®Google Scholar
• Remington G, Kapur S, Zipursky B. Pharmacotherapy of first-episode schizphrenia. British Journal of Psychiatry 1998; 172: 66–70
   Web of Science ®Google Scholar
• Kapur S, Remington G. Atypical antipsychotics. Patients value the lower incidence of extrapyramidal side effects. British Medical Journal 2000; 321: 1360–1361
   PubMedGoogle Scholar
• Geddes J. Prevention of relapse in schizophrenia. New England Journal of Medicine 2002; 356: 56–57
   Google Scholar
• Falloon I, Boyd J, McGill C, et al. Family management in the prevention of exacerbations of schizophrenia. New England Journal of Medicine 1982; 306: 1437–1440
   PubMed Web of Science ®Google Scholar
• Goldstein M, Rodrick E, Evans J, May P, Stenberg M. Drug and family therapy in the aftercare of acute schizophrenics. Archives of General Psychiatry 1978; 35: 1169–1177
   PubMed Web of Science ®Google Scholar
• Barraclough C, Tarrier N. Interventions with families. Psychological management of schizophrenia, M Birchwood, N Tarrier. Wiley, Chichester 1994
   Google Scholar
• Schooler N. Integration of family and drug treatment strategies in the treatment of schizophrenia: a selective review. International Clinical Psychopharmacology 1995; 10: 73–80
   PubMedGoogle Scholar
• Leff J, Kuipers L, Berkowitz R, Eberlein-Fries R, Sturgeon D. A controlled trial of intervention in the families of schizophrenic patients. British Journal of Psychiatry 1982; 146: 594–600
   Google Scholar
• Pilling S, Bebbington P, Kuipers E, et al. Psychological treatments in schizophrenia: 1. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine 2002; 32: 763–782
   PubMed Web of Science ®Google Scholar
• Tarrier N, Barrowclough C, Vaughn C, et al. The community management of schizophrenia: a controlled trial of a behavioural intervention with families to reduce relapse. British Journal of Psychiatry 1988; 153: 532–542
   PubMed Web of Science ®Google Scholar
• McGorry P. The concept of recovery and secondary prevention in psychotic disorders. Australian and New Zealand Journal of Psychiatry 1992; 26: 3–17
   PubMed Web of Science ®Google Scholar
• Birchwood M, Macmillan F. Early intervention in schizophrenia. Australian and New Zealand Journal of Psychiatry 1993; 27: 374–378
   PubMed Web of Science ®Google Scholar
• Tarrier N, Birchwood M. Making a reality of the community management of schizophrenia. Psychological management of schizophrenia, M Birchwood, N Tarrier. Wiley, Chichester 1994
   Google Scholar
• Drury V, Birchwood M, Cochrane M, Macmillan F. Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. II. Impact on recovery time. British Journal of Psychiatry 1996; 169: 593–607
   PubMed Web of Science ®Google Scholar
• Lewis S, Tarrier N, Haddock G, et al. Randomised controlled trial of cognitive behaviour therapy in early schizophrenia: Acute phase outcomes. British Journal of Psychiatry 2002:; 181:S91–S97
   Google Scholar
• McGorry P, Killackey E, Elkins K, Lamber M, Lambert T. Summary Australian and New Zealand clinical practice guideline for the treatment of schizophrenia. Australasian Psychiatry 2003; 11: 136–147
   Google Scholar
• McGrath J, McGlashan T. Improving outcomes for recent-onset psychoses: disentangling hope, speculation and evidence. Acta Psychiatrica Scandinavica 1999; 100: 83–84
   PubMed Web of Science ®Google Scholar
• McGorry P, Edwards J. The feasibility and effectiveness of early intervention in psychotic disorders: the Australian experience. International Clinical Psychopharmacology 1998:; 13: S47–S52
   Web of Science ®Google Scholar
• Power P, Elkins K, Adlard S, Curry C, McGorry P, Harrigan S. Analysis of the initial treatment phase in first-episode psychosis. British Journal of Psychiatry 1998; 172: 71–76
   Web of Science ®Google Scholar
• Mihalopoulos C, McGorry P, Carter R. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica 1999; 100: 47–55
   PubMed Web of Science ®Google Scholar
• McGorry P. Early psychosis reform: too fast or too slow? [Comment]. Acta Psychiatrica Scandinavica 2002; 106: 249–251
   PubMedGoogle Scholar
• Gorrell J, Cornish A, Tennant C, et al. An. audit of an early psychosis service: What are we doing differently?. Australian and New Zealand Journal of Psychiatry 2004; 38: 687–693
   PubMed Web of Science ®Google Scholar
• Gorrell J, Cornish A, Miller V, Nash L, Tennant C, Rosen A. Clinician attitudes towards early psychosis intervention: the first 4 years. Acta Psychiatrica Scandinavica 2002; 106: 92
   Google Scholar
• Tollefson G, Sanger T. Negative symptoms: a path analytic approach to a double-blind, placebo-and haloperidol-controlled clinical trial with olanzapine. American Journal of Psychiatry 1997; 154: 466–474
   PubMed Web of Science ®Google Scholar
• Duggan L, Fenton M, Dardennes R, El-Disily A, Indran S. Olanzapine for schizophrenia 2003, Cochrane Database of Systemic Reviews. CD001359
   Google Scholar
• Csernansky J, Mahmoud R, Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with achisophrenia. New England Journal of Medicine 2002; 346: 16–22
   PubMed Web of Science ®Google Scholar
• Kopelowicz A, Zarate R, Tripodis K, Gonzalez V, Mintz J. Differential Efficacy of Olanzapine for Deficit and Nondeficit Negative Symptoms in Schizphrenia. American Journal of Psychiatry 2000; 157: 987–993
   PubMed Web of Science ®Google Scholar
• Kennedy E, Song F, Hunter R, Clarke A, Gilbody S. Risperidone versus typical antipsychotic medication for schizophrenia 2000, Cochrane Database of Systemic Reviews CD000440
   Google Scholar
• Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systemic overview and meta-regression analysis. British Medical Journal 2000; 321: 1371–1376
   PubMed Web of Science ®Google Scholar
• Van Os J, Gilvany C, Bale R, et al. To what extent does symptomatic improvement result in better outcome in psychotic illness?. Psychological Medicine 1999; 29: 1183–1195
   PubMedGoogle Scholar
• Lukoff D, Liberman R, Nuechterlein K. Symptom monitoring in the rehabilitation of schizophrnic patients. Schizophrenia Bulletin 1986; 12: 579–593
   Google Scholar
• Andreason N. Negative symptoms in schizophrenia. Definition and Reliability. Archives of General Psychiatry 1982; 39: 784–788
   PubMed Web of Science ®Google Scholar
• Wing J, Curtis R, Beevor A. HoNOS: Health of the Nation Outcome Scales: report on research and development. Royal College of Psychiatrists, London 1996
   Google Scholar
• Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977; 1: 385–401
   Web of Science ®Google Scholar
• Pearce C, Martin G. Predicting Suicide attempts among adolescents. Acta Psychiatrica Scandinavica 1994; 90: 324–328
   PubMed Web of Science ®Google Scholar
• Belmont Center for Comprehensive Treatment. Adolescent drug abuse diagnosis. Belmont Center for Comprehensive Treatment, Philadelphia 1989
   Google Scholar
• Szmukler G, Burgess P, Herrman H, Benson A, Colusa S, Bloch S. Caring for relatives with serious mental illness. the development of the Experience of Caregiving Inventory. Social Psychiatry and Psychiatric Epidemiology 1996; 31: 137–148
   PubMed Web of Science ®Google Scholar
• Rosen A, Hadzi-Pavlovic D, Parker G. The Life Skills Profile: a measure assessing function and disability in schizophrenia. Schizophrenia Bulletin 1989; 15: 325–337
   PubMed Web of Science ®Google Scholar
• Roggeri M. The development and use of the Verona Expectations for Care Scale (VECS) and the Verona Service Satisfaction Scale (VSSS) for measuring expectations and satisfaction with community-based psychiatric services in patients, relatives and professionals. Psychological Medicine 1993:; 23: 511–523
   Google Scholar